Diabetes

Discover how adult-onset type 1 diabetes is linked to higher death rates and cardiovascular events, especially post-40 diagnosis.

New model predicts diabetes risk and recommends personalised prevention, including lifestyle changes or metformin, for diverse populations.

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

AI safely matches senior doctors in hospital insulin dosing for T2D, easing clinical load without compromising care.

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.